Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up

Sara Carazo; Danuta M. Skowronski; Nicholas Brousseau; Charles-Antoine Guay; Chantal Sauvageau; Étienne Racine; Denis Talbot; Iulia Gabriela Ionescu; Judith Fafard; Rodica Gilca; Jonathan Phimmasone; Philippe De Wals; Gaston De Serres

doi:10.1101/2024.11.13.24317190

Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up

View ORCID ProfileSara Carazo, View ORCID ProfileDanuta M. Skowronski, View ORCID ProfileNicholas Brousseau, View ORCID ProfileCharles-Antoine Guay, View ORCID ProfileChantal Sauvageau, View ORCID ProfileÉtienne Racine, View ORCID ProfileDenis Talbot, View ORCID ProfileIulia Gabriela Ionescu, View ORCID ProfileJudith Fafard, View ORCID ProfileRodica Gilca, Jonathan Phimmasone, View ORCID ProfilePhilippe De Wals, View ORCID ProfileGaston De Serres

doi: https://doi.org/10.1101/2024.11.13.24317190

Sara Carazo

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Sara Carazo
For correspondence: sara.carazo@inspq.qc.ca

Danuta M. Skowronski

4Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada

MD FRCPC

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Danuta M. Skowronski

Nicholas Brousseau

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

MD MSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nicholas Brousseau

Charles-Antoine Guay

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

5Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, Quebec, Canada

6Département des sciences de la santé communautaire, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Canada

MD M.Sc. FRCPC

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Charles-Antoine Guay

Chantal Sauvageau

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Chantal Sauvageau

Étienne Racine

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Étienne Racine

Denis Talbot

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Denis Talbot

Iulia Gabriela Ionescu

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

MSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Iulia Gabriela Ionescu

Judith Fafard

7Laboratoire de Santé Publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Judith Fafard

Rodica Gilca

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Rodica Gilca

Jonathan Phimmasone

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

MSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philippe De Wals

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Philippe De Wals

Gaston De Serres

2Social and preventive medicine department, Faculty of medicine, Laval University, Quebec City, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gaston De Serres

Abstract
Full Text
Info/History
Metrics
Supplementary material
Preview PDF

Supplemental material[supplements/317190_file02.pdf]

View the discussion thread.

PreviousNext

Posted November 13, 2024.

Download PDF

Supplementary Material

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up

Sara Carazo, Danuta M. Skowronski, Nicholas Brousseau, Charles-Antoine Guay, Chantal Sauvageau, Étienne Racine, Denis Talbot, Iulia Gabriela Ionescu, Judith Fafard, Rodica Gilca, Jonathan Phimmasone, Philippe De Wals, Gaston De Serres

medRxiv 2024.11.13.24317190; doi: https://doi.org/10.1101/2024.11.13.24317190

Share This Article:

Citation Tools

Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up

medRxiv 2024.11.13.24317190; doi: https://doi.org/10.1101/2024.11.13.24317190

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Infectious Diseases (except HIV/AIDS)

Subject Areas

All Articles

Addiction Medicine (390)
Allergy and Immunology (705)
Anesthesia (197)
Cardiovascular Medicine (2880)
Dentistry and Oral Medicine (327)
Dermatology (245)
Emergency Medicine (432)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1018)
Epidemiology (12614)
Forensic Medicine (10)
Gastroenterology (811)
Genetic and Genomic Medicine (4480)
Geriatric Medicine (407)
Health Economics (717)
Health Informatics (2868)
Health Policy (1059)
Health Systems and Quality Improvement (1057)
Hematology (378)
HIV/AIDS (909)
Infectious Diseases (except HIV/AIDS) (14026)
Intensive Care and Critical Care Medicine (835)
Medical Education (418)
Medical Ethics (115)
Nephrology (466)
Neurology (4241)
Nursing (228)
Nutrition (621)
Obstetrics and Gynecology (793)
Occupational and Environmental Health (726)
Oncology (2225)
Ophthalmology (632)
Orthopedics (255)
Otolaryngology (322)
Pain Medicine (270)
Palliative Medicine (83)
Pathology (489)
Pediatrics (1182)
Pharmacology and Therapeutics (491)
Primary Care Research (487)
Psychiatry and Clinical Psychology (3695)
Public and Global Health (6827)
Radiology and Imaging (1502)
Rehabilitation Medicine and Physical Therapy (875)
Respiratory Medicine (908)
Rheumatology (430)
Sexual and Reproductive Health (434)
Sports Medicine (374)
Surgery (475)
Toxicology (60)
Transplantation (204)
Urology (175)